SEC Form 4 · accession 0002065630-26-000008
MYRIAD GENETICS INC · MYGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian J Donnelly
Officer — Chief Commercial Officer
Period of report
Sep 16, 2026
Accepted (ET)
Sep 18, 2026 · 4:17 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000899923
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 573,363 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance-Based Restricted Stock UnitsF1 | — | holding | — | — | — | — | — | Common Stock | 236,167 | 236,167 | D |
Explanation of responses
- F1The shares subject to the performance-based restricted stock units ("PSUs") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones.
Remarks
This "Exit" Form 4 is voluntarily filed to report solely that, effective on September 16, 2026, the Reporting Person no longer serves in the role of Chief Commercial Officer of the Company, and therefore is no longer subject to Section 16 reporting.